hoe 33342 has been researched along with Adenoma, Prostatic in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Godoy, A; Huss, WJ; Mathew, G; Montecinos, VP; Smith, GJ; Sotomayor, P; Timm, EA | 1 |
Bhowmick, P; Bhowmick, S; Bischof, JC; Coad, JE; De La Rosette, J; Larson, T; Pryor, JL | 1 |
Brown, MD; Clarke, NW; George, NJ; Gilmore, PE; Hart, CA; Ramani, VA; Samuel, JD | 1 |
3 other study(ies) available for hoe 33342 and Adenoma, Prostatic
Article | Year |
---|---|
ABCG2-mediated DyeCycle Violet efflux defined side population in benign and malignant prostate.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzimidazoles; Cell Line; Cell Line, Tumor; Cell Separation; DNA; Fluorescent Dyes; Humans; Indoles; Intercalating Agents; Male; Mice; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms | 2009 |
In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia.
Topics: Benzimidazoles; Cell Survival; Ethidium; Fluorescent Dyes; Forecasting; Hot Temperature; Humans; Hyperthermia, Induced; Male; Microscopy, Fluorescence; Models, Biological; Prostate; Prostatic Hyperplasia; Stromal Cells; Time Factors; Tissue Culture Techniques; Treatment Outcome | 2004 |
Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations.
Topics: AC133 Antigen; Adult Stem Cells; Antigens, CD; Benzimidazoles; Cell Fractionation; Cell Growth Processes; Cell Line; Epithelial Cells; Flow Cytometry; Fluorescent Dyes; Glycoproteins; Humans; Immunohistochemistry; Immunophenotyping; Leukocyte Common Antigens; Male; Microscopy, Confocal; Peptides; Prostatic Hyperplasia; Prostatic Neoplasms | 2007 |